Home LiteratureArticle Details
PMID: 8132755 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.

The Journal of clinical investigation ·Vol. 93 ·No. 3 ·1994-03-00 ·Pages 1156-62

Kusari J, Kenner KA, Suh KI, Hill DE, Henry RR

Abstract

Particulate and cytosolic protein tyrosine phosphatase (PTPase) activity was measured in skeletal muscle from 15 insulin-sensitive subjects and 5 insulin-resistant nondiabetic subjects, as well as 18 subjects with non-insulin-dependent diabetes mellitus (NIDDM). Approximately 90% of total PTPase activity resided in the particulate fraction. In comparison with lean nondiabetic subjects, particulate PTPase activity was reduced 21% (P < 0.05) and 22% (P < 0.005) in obese nondiabetic and NIDDM subjects, respectively. PTPase1B protein levels were likewise decreased by 38% in NIDDM subjects (P < 0.05). During hyperinsulinemic glucose clamps, glucose disposal rates (GDR) increased approximately sixfold in lean control and twofold in NIDDM subjects, while particulate PTPase activity did not change. However, a strong positive correlation (r = 0.64, P < 0.001) existed between particulate PTPase activity and insulin-stimulated GDR. In five obese NIDDM subjects, weight loss of approximately 10% body wt resulted in a significant and corresponding increase in both particulate PTPase activity and insulin-stimulated GDR. These findings indicate that skeletal muscle particulate PTPase activity and PTPase1B protein content reflect in vivo insulin sensitivity and are reduced in insulin resistant states. We conclude that skeletal muscle PTPase activity is involved in the chronic, but not acute regulation of insulin action, and that the decreased enzyme activity may have a role in the insulin resistance of obesity and NIDDM.

MeSH Terms
Adult Diabetes Mellitus, Type 2/enzymology Glucose/metabolism Humans Insulin/pharmacology Insulin Resistance Middle Aged Muscles/enzymology Protein Tyrosine Phosphatases/analysis,metabolism Weight Loss
Chemicals
Insulin Protein Tyrosine Phosphatases Glucose
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kusari J
Department of Medicine, University of California, San Diego, La Jolla 92093.
Kenner K A
Suh K I
Hill D E
Henry R R
References (27)
27 references, click to expand
  1. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  2. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats.
    Endocrinology. 1993 Jan;132(1):67-74 PMID: 8419148
  3. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  4. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    J Clin Invest. 1981 Oct;68(4):957-69 PMID: 7287908
  5. Organic extraction of Pi with isobutanol/toluene.
    Anal Biochem. 1984 May 1;138(2):416-20 PMID: 6742419
  6. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.
    Nature. 1985 Feb 28-Mar 6;313(6005):756-61 PMID: 2983222
  7. Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus.
    Am J Med. 1985 Aug 23;79(2B):13-22 PMID: 3898828
  8. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.
    J Clin Invest. 1986 Jul;78(1):249-58 PMID: 3522628
  9. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus.
    Diabetes. 1986 Sep;35(9):990-8 PMID: 3527829
  10. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.
    J Clin Invest. 1987 Jan;79(1):240-50 PMID: 3540010
  11. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.
    Cell. 1987 Apr 10;49(1):65-73 PMID: 3103925
  12. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src.
    Cell. 1987 Apr 10;49(1):75-82 PMID: 3103926
  13. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.
    Cell. 1987 Apr 10;49(1):83-91 PMID: 3103927
  14. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
    Diabetes. 1987 May;36(5):620-5 PMID: 3032715
  15. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.
    J Clin Invest. 1987 May;79(5):1330-7 PMID: 3033021
  16. Assay of phosphotyrosyl protein phosphatase using synthetic peptide 1142-1153 of the insulin receptor.
    FEBS Lett. 1988 Sep 12;237(1-2):137-40 PMID: 2844584
  17. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Am J Med. 1988 Nov 28;85(5A):86-105 PMID: 3057897
  18. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
    J Clin Invest. 1990 Feb;85(2):522-9 PMID: 2105341
  19. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    J Clin Endocrinol Metab. 1990 Jun;70(6):1594-602 PMID: 2189885
  20. Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.
    Diabetes. 1990 Feb;39(2):149-56 PMID: 2227122
  21. Phosphotyrosyl turnover in insulin signaling. Characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes.
    J Biol Chem. 1991 Apr 5;266(10):6544-53 PMID: 1848858
  22. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.
    J Clin Invest. 1991 Apr;87(4):1286-94 PMID: 1707061
  23. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans.
    Diabetes. 1991 Jul;40(7):939-42 PMID: 1647997
  24. Activation of membrane protein-tyrosine phosphatase involving cAMP- and Ca2+/phospholipid-dependent protein kinases.
    Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6696-700 PMID: 1650478
  25. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.
    J Clin Invest. 1992 Feb;89(2):701-5 PMID: 1737857
  26. Protein-tyrosine phosphatases and the regulation of insulin action.
    J Cell Biochem. 1992 Jan;48(1):33-42 PMID: 1316360
  27. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1994-03-00
Pages
1156-62
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC294066
Subset
IM
Grants
NIDDK NIH HHS · DK 38949 · United States
NCRR NIH HHS · MO1 RR00827 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com